54 related articles for article (PubMed ID: 10723132)
1. An IFN regulatory factor-2 DNA-binding domain dominant negative mutant exhibits altered cell growth and gene expression.
Rubinstein YR; Driggers PH; Ogryzko VV; Thornton AM; Ozato K; Pontzer CH
Oncogene; 2000 Mar; 19(11):1411-8. PubMed ID: 10723132
[TBL] [Abstract][Full Text] [Related]
2. A dominant negative mutant of an IFN regulatory factor family protein inhibits both type I and type II IFN-stimulated gene expression and antiproliferative activity of IFNs.
Thornton AM; Ogryzko VV; Dent A; Sharf R; Levi BZ; Kanno Y; Staudt LM; Howard BH; Ozato K
J Immunol; 1996 Dec; 157(11):5145-54. PubMed ID: 8943426
[TBL] [Abstract][Full Text] [Related]
3. Interferon-gamma regulation of the human mimecan promoter.
Tasheva ES; Conrad GW
Mol Vis; 2003 Jun; 9():277-87. PubMed ID: 12835654
[TBL] [Abstract][Full Text] [Related]
4. Regulation of TGFbeta1-mediated growth inhibition and apoptosis by RUNX2 isoforms in endothelial cells.
Sun L; Vitolo MI; Qiao M; Anglin IE; Passaniti A
Oncogene; 2004 Jun; 23(27):4722-34. PubMed ID: 15107836
[TBL] [Abstract][Full Text] [Related]
5. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.
Huang L; Sowa Y; Sakai T; Pardee AB
Oncogene; 2000 Nov; 19(50):5712-9. PubMed ID: 11126357
[TBL] [Abstract][Full Text] [Related]
6. Forced expression of the interferon regulatory factor 2 oncoprotein causes polyploidy and cell death in FDC-P1 myeloid hematopoietic progenitor cells.
Xie RL; van Wijnen AJ; van der Meijden CM; Stein JL; Stein GS
Cancer Res; 2002 May; 62(9):2510-5. PubMed ID: 11980642
[TBL] [Abstract][Full Text] [Related]
7. Tumor-suppressor effect of interferon regulatory factor-1 in human hepatocellular carcinoma.
Moriyama Y; Nishiguchi S; Tamori A; Koh N; Yano Y; Kubo S; Hirohashi K; Otani S
Clin Cancer Res; 2001 May; 7(5):1293-8. PubMed ID: 11350897
[TBL] [Abstract][Full Text] [Related]
8. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
Foos G; Hauser CA
Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
[TBL] [Abstract][Full Text] [Related]
9. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
10. The interferon regulatory factors 1 and 2 bind to a segment of the human c-myb first intron: possible role in the regulation of c-myb expression.
Manzella L; Gualdi R; Perrotti D; Nicolaides NC; Girlando G; Giuffrida MA; Messina A; Calabretta B
Exp Cell Res; 2000 Apr; 256(1):248-56. PubMed ID: 10739671
[TBL] [Abstract][Full Text] [Related]
11. KLF2 inhibits Jurkat T leukemia cell growth via upregulation of cyclin-dependent kinase inhibitor p21WAF1/CIP1.
Wu J; Lingrel JB
Oncogene; 2004 Oct; 23(49):8088-96. PubMed ID: 15361832
[TBL] [Abstract][Full Text] [Related]
12. Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2).
van der Fits L; van der Wel LI; Laman JD; Prens EP; Verschuren MC
J Pathol; 2003 Jan; 199(1):107-14. PubMed ID: 12474233
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of IRF3 and IRF7 in rainbow trout, Oncorhynchus mykiss: functional analysis and transcriptional modulation.
Holland JW; Bird S; Williamson B; Woudstra C; Mustafa A; Wang T; Zou J; Blaney SC; Collet B; Secombes CJ
Mol Immunol; 2008 Dec; 46(2):269-85. PubMed ID: 18805586
[TBL] [Abstract][Full Text] [Related]
14. Dose-dependent activation of p21WAF1 transcription by all-trans-acid in cervical squamous carcinoma cells.
Arany I; Whitehead WE; Ember IA; Tyring SK
Anticancer Res; 2003; 23(1A):495-7. PubMed ID: 12680256
[TBL] [Abstract][Full Text] [Related]
15. KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway.
Gao SJ; Boshoff C; Jayachandra S; Weiss RA; Chang Y; Moore PS
Oncogene; 1997 Oct; 15(16):1979-85. PubMed ID: 9365244
[TBL] [Abstract][Full Text] [Related]
16. Induction of p21WAF1 expression via Sp1-binding sites by tamoxifen in estrogen receptor-negative lung cancer cells.
Lee TH; Chuang LY; Hung WC
Oncogene; 2000 Aug; 19(33):3766-73. PubMed ID: 10949931
[TBL] [Abstract][Full Text] [Related]
17. A c-fos/Estrogen receptor fusion protein promotes cell cycle progression and proliferation of human cancer cell lines.
Crowe DL; Brown TN; Kim R; Smith SM; Lee MK
Mol Cell Biol Res Commun; 2000 Apr; 3(4):243-8. PubMed ID: 10891399
[TBL] [Abstract][Full Text] [Related]
18. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
Seoane J; Le HV; Massagué J
Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
[TBL] [Abstract][Full Text] [Related]
19. The role of the interferon regulatory factors, IRF-1 and IRF-2, in LPS-induced cyclooxygenase-2 (COX-2) expression in vivo and in vitro.
Zhang S; Thomas K; Blanco JC; Salkowski CA; Vogel SN
J Endotoxin Res; 2002; 8(5):379-88. PubMed ID: 12537697
[TBL] [Abstract][Full Text] [Related]
20. Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells.
Miyazaki M; Sakaguchi M; Akiyama I; Sakaguchi Y; Nagamori S; Huh NH
Cancer Res; 2004 Jun; 64(12):4155-61. PubMed ID: 15205326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
